▶ 調査レポート

ライブバイオセラピューティック製品のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Live Biotherapeutic Products Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ライブバイオセラピューティック製品のグローバル市場インサイト・予測(~2028年) / Global Live Biotherapeutic Products Market Insights, Forecast to 2028 / QY2207E09243資料のイメージです。• レポートコード:QY2207E09243
• 出版社/出版日:QYResearch / 2022年7月
• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,102,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のライブバイオセラピューティック製品の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にライブバイオセラピューティック製品の世界市場のxxx%を占める「固形物」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「自己免疫疾患」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のライブバイオセラピューティック製品の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのライブバイオセラピューティック製品市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのライブバイオセラピューティック製品市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ライブバイオセラピューティック製品のグローバル主要メーカーには、Capsugel、Jeneil Biotech、UAS Labs、Biose、Cerbios-Pharma、Inpac Probiotics、NIZO、Winclove Probiotics、BJP Laboratoriesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ライブバイオセラピューティック製品市場は、種類と用途によって区分されます。世界のライブバイオセラピューティック製品市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
固形物、経口液剤、注射剤、その他

【用途別セグメント】
自己免疫疾患、消化器系疾患、感染症、代謝性疾患、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ライブバイオセラピューティック製品製品概要
- 種類別市場(固形物、経口液剤、注射剤、その他)
- 用途別市場(自己免疫疾患、消化器系疾患、感染症、代謝性疾患、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のライブバイオセラピューティック製品販売量予測2017-2028
- 世界のライブバイオセラピューティック製品売上予測2017-2028
- ライブバイオセラピューティック製品の地域別販売量
- ライブバイオセラピューティック製品の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ライブバイオセラピューティック製品販売量
- 主要メーカー別ライブバイオセラピューティック製品売上
- 主要メーカー別ライブバイオセラピューティック製品価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(固形物、経口液剤、注射剤、その他)
- ライブバイオセラピューティック製品の種類別販売量
- ライブバイオセラピューティック製品の種類別売上
- ライブバイオセラピューティック製品の種類別価格
・用途別市場規模(自己免疫疾患、消化器系疾患、感染症、代謝性疾患、その他)
- ライブバイオセラピューティック製品の用途別販売量
- ライブバイオセラピューティック製品の用途別売上
- ライブバイオセラピューティック製品の用途別価格
・北米市場
- 北米のライブバイオセラピューティック製品市場規模(種類別、用途別)
- 主要国別のライブバイオセラピューティック製品市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのライブバイオセラピューティック製品市場規模(種類別、用途別)
- 主要国別のライブバイオセラピューティック製品市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のライブバイオセラピューティック製品市場規模(種類別、用途別)
- 主要国別のライブバイオセラピューティック製品市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のライブバイオセラピューティック製品市場規模(種類別、用途別)
- 主要国別のライブバイオセラピューティック製品市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのライブバイオセラピューティック製品市場規模(種類別、用途別)
- 主要国別のライブバイオセラピューティック製品市場規模(トルコ、サウジアラビア)
・企業情報
Capsugel、Jeneil Biotech、UAS Labs、Biose、Cerbios-Pharma、Inpac Probiotics、NIZO、Winclove Probiotics、BJP Laboratories
・産業チェーン及び販売チャネル分析
- ライブバイオセラピューティック製品の産業チェーン分析
- ライブバイオセラピューティック製品の原材料
- ライブバイオセラピューティック製品の生産プロセス
- ライブバイオセラピューティック製品の販売及びマーケティング
- ライブバイオセラピューティック製品の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ライブバイオセラピューティック製品の産業動向
- ライブバイオセラピューティック製品のマーケットドライバー
- ライブバイオセラピューティック製品の課題
- ライブバイオセラピューティック製品の阻害要因
・主な調査結果

Market Analysis and Insights: Global Live Biotherapeutic Products Market
The global Live Biotherapeutic Products market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Solids accounting for % of the Live Biotherapeutic Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Autoimmune Disease segment is altered to an % CAGR throughout this forecast period.
China Live Biotherapeutic Products market size is valued at US$ million in 2021, while the North America and Europe Live Biotherapeutic Products are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Live Biotherapeutic Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Live Biotherapeutic Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Live Biotherapeutic Products market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Live Biotherapeutic Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Live Biotherapeutic Products market.
Global Live Biotherapeutic Products Scope and Market Size
Live Biotherapeutic Products market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Live Biotherapeutic Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Solids
Oral Liquids
Injectables
Others
Segment by Application
Autoimmune Disease
Digestive System Diseases
Infectious Disease
Metabolic Disease
Others
By Company
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Live Biotherapeutic Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Solids
1.2.3 Oral Liquids
1.2.4 Injectables
1.2.5 Others
1.3 Market by Application
1.3.1 Global Live Biotherapeutic Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Autoimmune Disease
1.3.3 Digestive System Diseases
1.3.4 Infectious Disease
1.3.5 Metabolic Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Live Biotherapeutic Products Market Perspective (2017-2028)
2.2 Live Biotherapeutic Products Growth Trends by Region
2.2.1 Live Biotherapeutic Products Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Live Biotherapeutic Products Historic Market Size by Region (2017-2022)
2.2.3 Live Biotherapeutic Products Forecasted Market Size by Region (2023-2028)
2.3 Live Biotherapeutic Products Market Dynamics
2.3.1 Live Biotherapeutic Products Industry Trends
2.3.2 Live Biotherapeutic Products Market Drivers
2.3.3 Live Biotherapeutic Products Market Challenges
2.3.4 Live Biotherapeutic Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Live Biotherapeutic Products Players by Revenue
3.1.1 Global Top Live Biotherapeutic Products Players by Revenue (2017-2022)
3.1.2 Global Live Biotherapeutic Products Revenue Market Share by Players (2017-2022)
3.2 Global Live Biotherapeutic Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Live Biotherapeutic Products Revenue
3.4 Global Live Biotherapeutic Products Market Concentration Ratio
3.4.1 Global Live Biotherapeutic Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Live Biotherapeutic Products Revenue in 2021
3.5 Live Biotherapeutic Products Key Players Head office and Area Served
3.6 Key Players Live Biotherapeutic Products Product Solution and Service
3.7 Date of Enter into Live Biotherapeutic Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Live Biotherapeutic Products Breakdown Data by Type
4.1 Global Live Biotherapeutic Products Historic Market Size by Type (2017-2022)
4.2 Global Live Biotherapeutic Products Forecasted Market Size by Type (2023-2028)
5 Live Biotherapeutic Products Breakdown Data by Application
5.1 Global Live Biotherapeutic Products Historic Market Size by Application (2017-2022)
5.2 Global Live Biotherapeutic Products Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Live Biotherapeutic Products Market Size (2017-2028)
6.2 North America Live Biotherapeutic Products Market Size by Type
6.2.1 North America Live Biotherapeutic Products Market Size by Type (2017-2022)
6.2.2 North America Live Biotherapeutic Products Market Size by Type (2023-2028)
6.2.3 North America Live Biotherapeutic Products Market Share by Type (2017-2028)
6.3 North America Live Biotherapeutic Products Market Size by Application
6.3.1 North America Live Biotherapeutic Products Market Size by Application (2017-2022)
6.3.2 North America Live Biotherapeutic Products Market Size by Application (2023-2028)
6.3.3 North America Live Biotherapeutic Products Market Share by Application (2017-2028)
6.4 North America Live Biotherapeutic Products Market Size by Country
6.4.1 North America Live Biotherapeutic Products Market Size by Country (2017-2022)
6.4.2 North America Live Biotherapeutic Products Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Live Biotherapeutic Products Market Size (2017-2028)
7.2 Europe Live Biotherapeutic Products Market Size by Type
7.2.1 Europe Live Biotherapeutic Products Market Size by Type (2017-2022)
7.2.2 Europe Live Biotherapeutic Products Market Size by Type (2023-2028)
7.2.3 Europe Live Biotherapeutic Products Market Share by Type (2017-2028)
7.3 Europe Live Biotherapeutic Products Market Size by Application
7.3.1 Europe Live Biotherapeutic Products Market Size by Application (2017-2022)
7.3.2 Europe Live Biotherapeutic Products Market Size by Application (2023-2028)
7.3.3 Europe Live Biotherapeutic Products Market Share by Application (2017-2028)
7.4 Europe Live Biotherapeutic Products Market Size by Country
7.4.1 Europe Live Biotherapeutic Products Market Size by Country (2017-2022)
7.4.2 Europe Live Biotherapeutic Products Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Live Biotherapeutic Products Market Size (2017-2028)
8.2 Asia-Pacific Live Biotherapeutic Products Market Size by Type
8.2.1 Asia-Pacific Live Biotherapeutic Products Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Live Biotherapeutic Products Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Live Biotherapeutic Products Market Share by Type (2017-2028)
8.3 Asia-Pacific Live Biotherapeutic Products Market Size by Application
8.3.1 Asia-Pacific Live Biotherapeutic Products Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Live Biotherapeutic Products Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Live Biotherapeutic Products Market Share by Application (2017-2028)
8.4 Asia-Pacific Live Biotherapeutic Products Market Size by Region
8.4.1 Asia-Pacific Live Biotherapeutic Products Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Live Biotherapeutic Products Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Live Biotherapeutic Products Market Size (2017-2028)
9.2 Latin America Live Biotherapeutic Products Market Size by Type
9.2.1 Latin America Live Biotherapeutic Products Market Size by Type (2017-2022)
9.2.2 Latin America Live Biotherapeutic Products Market Size by Type (2023-2028)
9.2.3 Latin America Live Biotherapeutic Products Market Share by Type (2017-2028)
9.3 Latin America Live Biotherapeutic Products Market Size by Application
9.3.1 Latin America Live Biotherapeutic Products Market Size by Application (2017-2022)
9.3.2 Latin America Live Biotherapeutic Products Market Size by Application (2023-2028)
9.3.3 Latin America Live Biotherapeutic Products Market Share by Application (2017-2028)
9.4 Latin America Live Biotherapeutic Products Market Size by Country
9.4.1 Latin America Live Biotherapeutic Products Market Size by Country (2017-2022)
9.4.2 Latin America Live Biotherapeutic Products Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Live Biotherapeutic Products Market Size (2017-2028)
10.2 Middle East & Africa Live Biotherapeutic Products Market Size by Type
10.2.1 Middle East & Africa Live Biotherapeutic Products Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Live Biotherapeutic Products Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Live Biotherapeutic Products Market Share by Type (2017-2028)
10.3 Middle East & Africa Live Biotherapeutic Products Market Size by Application
10.3.1 Middle East & Africa Live Biotherapeutic Products Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Live Biotherapeutic Products Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Live Biotherapeutic Products Market Share by Application (2017-2028)
10.4 Middle East & Africa Live Biotherapeutic Products Market Size by Country
10.4.1 Middle East & Africa Live Biotherapeutic Products Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Live Biotherapeutic Products Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Capsugel
11.1.1 Capsugel Company Details
11.1.2 Capsugel Business Overview
11.1.3 Capsugel Live Biotherapeutic Products Introduction
11.1.4 Capsugel Revenue in Live Biotherapeutic Products Business (2017-2022)
11.1.5 Capsugel Recent Developments
11.2 Jeneil Biotech
11.2.1 Jeneil Biotech Company Details
11.2.2 Jeneil Biotech Business Overview
11.2.3 Jeneil Biotech Live Biotherapeutic Products Introduction
11.2.4 Jeneil Biotech Revenue in Live Biotherapeutic Products Business (2017-2022)
11.2.5 Jeneil Biotech Recent Developments
11.3 UAS Labs
11.3.1 UAS Labs Company Details
11.3.2 UAS Labs Business Overview
11.3.3 UAS Labs Live Biotherapeutic Products Introduction
11.3.4 UAS Labs Revenue in Live Biotherapeutic Products Business (2017-2022)
11.3.5 UAS Labs Recent Developments
11.4 Biose
11.4.1 Biose Company Details
11.4.2 Biose Business Overview
11.4.3 Biose Live Biotherapeutic Products Introduction
11.4.4 Biose Revenue in Live Biotherapeutic Products Business (2017-2022)
11.4.5 Biose Recent Developments
11.5 Cerbios-Pharma
11.5.1 Cerbios-Pharma Company Details
11.5.2 Cerbios-Pharma Business Overview
11.5.3 Cerbios-Pharma Live Biotherapeutic Products Introduction
11.5.4 Cerbios-Pharma Revenue in Live Biotherapeutic Products Business (2017-2022)
11.5.5 Cerbios-Pharma Recent Developments
11.6 Inpac Probiotics
11.6.1 Inpac Probiotics Company Details
11.6.2 Inpac Probiotics Business Overview
11.6.3 Inpac Probiotics Live Biotherapeutic Products Introduction
11.6.4 Inpac Probiotics Revenue in Live Biotherapeutic Products Business (2017-2022)
11.6.5 Inpac Probiotics Recent Developments
11.7 NIZO
11.7.1 NIZO Company Details
11.7.2 NIZO Business Overview
11.7.3 NIZO Live Biotherapeutic Products Introduction
11.7.4 NIZO Revenue in Live Biotherapeutic Products Business (2017-2022)
11.7.5 NIZO Recent Developments
11.8 Winclove Probiotics
11.8.1 Winclove Probiotics Company Details
11.8.2 Winclove Probiotics Business Overview
11.8.3 Winclove Probiotics Live Biotherapeutic Products Introduction
11.8.4 Winclove Probiotics Revenue in Live Biotherapeutic Products Business (2017-2022)
11.8.5 Winclove Probiotics Recent Developments
11.9 BJP Laboratories
11.9.1 BJP Laboratories Company Details
11.9.2 BJP Laboratories Business Overview
11.9.3 BJP Laboratories Live Biotherapeutic Products Introduction
11.9.4 BJP Laboratories Revenue in Live Biotherapeutic Products Business (2017-2022)
11.9.5 BJP Laboratories Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Live Biotherapeutic Products Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Solids
Table 3. Key Players of Oral Liquids
Table 4. Key Players of Injectables
Table 5. Key Players of Others
Table 6. Global Live Biotherapeutic Products Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Live Biotherapeutic Products Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Live Biotherapeutic Products Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Live Biotherapeutic Products Market Share by Region (2017-2022)
Table 10. Global Live Biotherapeutic Products Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Live Biotherapeutic Products Market Share by Region (2023-2028)
Table 12. Live Biotherapeutic Products Market Trends
Table 13. Live Biotherapeutic Products Market Drivers
Table 14. Live Biotherapeutic Products Market Challenges
Table 15. Live Biotherapeutic Products Market Restraints
Table 16. Global Live Biotherapeutic Products Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Live Biotherapeutic Products Revenue Share by Players (2017-2022)
Table 18. Global Top Live Biotherapeutic Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products as of 2021)
Table 19. Ranking of Global Top Live Biotherapeutic Products Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Live Biotherapeutic Products Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Live Biotherapeutic Products Product Solution and Service
Table 23. Date of Enter into Live Biotherapeutic Products Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Live Biotherapeutic Products Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Live Biotherapeutic Products Revenue Market Share by Type (2017-2022)
Table 27. Global Live Biotherapeutic Products Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Live Biotherapeutic Products Revenue Market Share by Type (2023-2028)
Table 29. Global Live Biotherapeutic Products Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Live Biotherapeutic Products Revenue Share by Application (2017-2022)
Table 31. Global Live Biotherapeutic Products Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Live Biotherapeutic Products Revenue Share by Application (2023-2028)
Table 33. North America Live Biotherapeutic Products Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Live Biotherapeutic Products Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Live Biotherapeutic Products Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Live Biotherapeutic Products Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Live Biotherapeutic Products Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Live Biotherapeutic Products Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Live Biotherapeutic Products Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Live Biotherapeutic Products Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Live Biotherapeutic Products Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Live Biotherapeutic Products Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Live Biotherapeutic Products Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Live Biotherapeutic Products Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Live Biotherapeutic Products Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Live Biotherapeutic Products Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Live Biotherapeutic Products Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Live Biotherapeutic Products Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Live Biotherapeutic Products Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Live Biotherapeutic Products Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Live Biotherapeutic Products Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Live Biotherapeutic Products Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Live Biotherapeutic Products Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Live Biotherapeutic Products Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Live Biotherapeutic Products Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Live Biotherapeutic Products Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Live Biotherapeutic Products Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Live Biotherapeutic Products Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Live Biotherapeutic Products Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Live Biotherapeutic Products Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Live Biotherapeutic Products Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Live Biotherapeutic Products Market Size by Country (2023-2028) & (US$ Million)
Table 63. Capsugel Company Details
Table 64. Capsugel Business Overview
Table 65. Capsugel Live Biotherapeutic Products Product
Table 66. Capsugel Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 67. Capsugel Recent Developments
Table 68. Jeneil Biotech Company Details
Table 69. Jeneil Biotech Business Overview
Table 70. Jeneil Biotech Live Biotherapeutic Products Product
Table 71. Jeneil Biotech Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 72. Jeneil Biotech Recent Developments
Table 73. UAS Labs Company Details
Table 74. UAS Labs Business Overview
Table 75. UAS Labs Live Biotherapeutic Products Product
Table 76. UAS Labs Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 77. UAS Labs Recent Developments
Table 78. Biose Company Details
Table 79. Biose Business Overview
Table 80. Biose Live Biotherapeutic Products Product
Table 81. Biose Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 82. Biose Recent Developments
Table 83. Cerbios-Pharma Company Details
Table 84. Cerbios-Pharma Business Overview
Table 85. Cerbios-Pharma Live Biotherapeutic Products Product
Table 86. Cerbios-Pharma Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 87. Cerbios-Pharma Recent Developments
Table 88. Inpac Probiotics Company Details
Table 89. Inpac Probiotics Business Overview
Table 90. Inpac Probiotics Live Biotherapeutic Products Product
Table 91. Inpac Probiotics Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 92. Inpac Probiotics Recent Developments
Table 93. NIZO Company Details
Table 94. NIZO Business Overview
Table 95. NIZO Live Biotherapeutic Products Product
Table 96. NIZO Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 97. NIZO Recent Developments
Table 98. Winclove Probiotics Company Details
Table 99. Winclove Probiotics Business Overview
Table 100. Winclove Probiotics Live Biotherapeutic Products Product
Table 101. Winclove Probiotics Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 102. Winclove Probiotics Recent Developments
Table 103. BJP Laboratories Company Details
Table 104. BJP Laboratories Business Overview
Table 105. BJP Laboratories Live Biotherapeutic Products Product
Table 106. BJP Laboratories Revenue in Live Biotherapeutic Products Business (2017-2022) & (US$ Million)
Table 107. BJP Laboratories Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Live Biotherapeutic Products Market Share by Type: 2021 VS 2028
Figure 2. Solids Features
Figure 3. Oral Liquids Features
Figure 4. Injectables Features
Figure 5. Others Features
Figure 6. Global Live Biotherapeutic Products Market Share by Application: 2021 VS 2028
Figure 7. Autoimmune Disease Case Studies
Figure 8. Digestive System Diseases Case Studies
Figure 9. Infectious Disease Case Studies
Figure 10. Metabolic Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Live Biotherapeutic Products Report Years Considered
Figure 13. Global Live Biotherapeutic Products Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Live Biotherapeutic Products Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Live Biotherapeutic Products Market Share by Region: 2021 VS 2028
Figure 16. Global Live Biotherapeutic Products Market Share by Players in 2021
Figure 17. Global Top Live Biotherapeutic Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Live Biotherapeutic Products Revenue in 2021
Figure 19. North America Live Biotherapeutic Products Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Live Biotherapeutic Products Market Size Market Share by Type (2017-2028)
Figure 21. North America Live Biotherapeutic Products Market Size Market Share by Application (2017-2028)
Figure 22. North America Live Biotherapeutic Products Market Size Share by Country (2017-2028)
Figure 23. United States Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Live Biotherapeutic Products Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Live Biotherapeutic Products Market Size Market Share by Type (2017-2028)
Figure 27. Europe Live Biotherapeutic Products Market Size Market Share by Application (2017-2028)
Figure 28. Europe Live Biotherapeutic Products Market Size Share by Country (2017-2028)
Figure 29. Germany Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Live Biotherapeutic Products Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Live Biotherapeutic Products Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Live Biotherapeutic Products Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Live Biotherapeutic Products Market Size Share by Region (2017-2028)
Figure 39. China Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Live Biotherapeutic Products Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Live Biotherapeutic Products Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Live Biotherapeutic Products Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Live Biotherapeutic Products Market Size Share by Country (2017-2028)
Figure 49. Mexico Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Live Biotherapeutic Products Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Live Biotherapeutic Products Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Live Biotherapeutic Products Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Live Biotherapeutic Products Market Size Share by Country (2017-2028)
Figure 55. Turkey Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Live Biotherapeutic Products Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Capsugel Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 59. Jeneil Biotech Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 60. UAS Labs Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 61. Biose Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 62. Cerbios-Pharma Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 63. Inpac Probiotics Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 64. NIZO Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 65. Winclove Probiotics Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 66. BJP Laboratories Revenue Growth Rate in Live Biotherapeutic Products Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed